Variations of coxsackievirus B3 capsid primary structure, ligands, and stability are selected for in a coxsackievirus and adenovirus receptor-limited environment

Journal of Virology

Volumn 85, Issue 7, 2011, Pages 3306-3314

  Carson, Steven D ^a   Chapman, Nora M ^a   Hafenstein, Susan ^b   Tracy, Steven ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAPSID PROTEIN; COXSACKIE VIRUS AND ADENOVIRUS RECEPTOR; DECAY ACCELERATING FACTOR; GLUTAMIC ACID; GLUTAMINE;

ARTICLE; BINDING SITE; CONTROLLED STUDY; COXSACKIE VIRUS B3; ERYTHROCYTE; HELA CELL; HUMAN; HUMAN CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RAJI CELL; VIRUS ATTACHMENT; VIRUS CAPSID; VIRUS CELL INTERACTION; VIRUS STRAIN;

AMINO ACID SUBSTITUTION; CAPSID PROTEINS; DNA MUTATIONAL ANALYSIS; ENTEROVIRUS B, HUMAN; GENETIC VARIATION; HELA CELLS; HUMANS; MOLECULAR SEQUENCE DATA; MUTATION, MISSENSE; PROTEIN BINDING; RECEPTORS, VIRUS; SELECTION, GENETIC; SEQUENCE ANALYSIS, DNA; SERIAL PASSAGE; VIRUS ATTACHMENT;

ADENOVIRIDAE; COXSACKIEVIRUS; MIRIDAE;

EID: 79952614423     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01827-10     Document Type: Article

References (23)

1. Bergelson, J. M., et al. 1995. Coxsackievirus B3 adapted to growth in RD cells binds to decay accelerating factor (CD55). J. Virol. 69:1903-1906.
2. Carson, S. D. 2000. Limited proteolysis of the coxsackievirus and adenovirus receptor (CAR) on HeLa cells exposed to trypsin. FEBS Lett. 484:149-152.
3. Carson, S. D., N. M. Chapman, and S. M. Tracy. 1997. Purification of the putative coxsackievirus B receptor from HeLa cells. Biochem. Biophys. Res. Commun. 233:325-328.
4. Carson, S. D., J. T. Hobbs, S. M. Tracy, and N. M. Chapman. 1999. Expression of the coxsackievirus and adenovirus receptor in cultured human umbilical vein endothelial cells: regulation in response to cell density. J. Virol. 73:7077-7079.
5. Carson, S. D., K.-S. Kim, S. J. Pirruccello, S. Tracy, and N. M. Chapman. 2007. Endogenous low-level expression of the coxsackievirus and adenovirus receptor enables coxsackievirus B3 infection of RD cells. J. Gen. Virol. 88:3031-3038.
6. Coyne, C. B., and J. M. Bergelson. 2006. Virus-induced Abl and Fyn kinase signals permit coxsackievirus entry through epithelial tight junctions. Cell 124:119-131.
7. Cunningham, K. A., N. M. Chapman, and S. D. Carson. 2003. Caspase-3 activation and ERK phosphorylation during CVB3 infection of cells: influence of the coxsackievirus and adenovirus receptor and engineered variants. Virus Res. 92:179-186.
8. de Verdugo, U. R., et al. 1995. Characterization of a 100-kilodalton binding protein for the six serotypes of coxsackie B viruses. J. Virol. 69:6751-6757.
9. Goodfellow, I. G., et al. 2005. Inhibition of coxsackie B virus infection by soluble forms of its receptors: binding affinities, altered particle formation, and competition with cellular receptors. J. Virol. 79:12016-12024. (Pubitemid 41279318)
10. Hafenstein, S., et al. 2007. Interaction of decay-accelerating factor with coxsackievirus B3. J. Virol. 81:12927-12935. (Pubitemid 350156930)
11. He, Y., et al. 2001. Interaction of coxsackievirus B3 with the full length coxsackievirus-adenovirus receptor. Nat. Struct. Biol. 8:874-878.
12. Hsu, K. H., K. Lonberg-Holm, B. Alstein, and R. L. Crowell. 1988. A monoclonal antibody specific for the cellular receptor for the group B coxsackieviruses. J. Virol. 62:1647-1652.
13. Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685.
14. Milstone, A. M., et al. 2005. Interaction with coxsackievirus and adenovirus receptor, but not with decay-accelerating factor (DAF), induces A-particle formation in a DAF-binding coxsackievirus B3 isolate. J. Virol. 79:655-660. (Pubitemid 39648422)
15. Muckelbauer, J. K., et al. 1995. Structure determination of coxsackievirus B3 to 3.5 A resolution. Acta Crystallogr. D Biol. Crystallogr. 51:871-877.
16. Patel, K., C. B. Coyne, and J. M. Bergelson. 2009. Dynamin- and lipid raft-dependent entry of decay accelerating factor (DAF)-binding and non- DAF-binding coxsackieviruses into nonpolarized cells. J. Virol. 83:11064-11077.
17. Powell, R. M., T. Ward, I. Goodfellow, J. W. Almond, and D. J. Evans. 1999. Mapping the binding domains on decay accelerating factor (DAF) for hemagglutinating enteroviruses: implications for the evolution of a DAF-binding phenotype. J. Gen. Virol. 80:3145-3152.
18. Reagan, K. J., B. Goldberg, and R. L. Crowell. 1984. Altered receptor specificity of coxsackievirus B3 after growth in rhabdomyosarcoma cells. J. Virol. 49:635-640.
19. Schmidtke, M., et al. 2000. Attachment of coxsackievirus B3 variants to various cell lines: mapping of phenotypic differences in capsid protein VP1. Virology 275:77-88.
20. Shafren, D. R., et al. 1995. Coxsackieviruses B1, B3, and B5 use decay accelerating factor as a receptor for cell attachment. J. Virol. 69:3873-3877.
21. Shafren, D. R., D. T. Williams, and R. D. Barry. 1997. A decay-accelerating factor-binding strain of coxsackievirus B3 requires the coxsackievirus-adenovirus receptor protein to mediate lytic infection of rhabdomyosarcoma cells. J. Virol. 71:9844-9848.
22. Tu, Z., et al. 1995. The cardiovirulent phenotype of coxsackievirus B3 is determined at a single site in the 5′ nontranslated region. J. Virol. 69:4607-4618.
23. Zautner, A. E., U. Korner, A. Henke, C. Badorff, and M. Schmidtke. 2003. Heparan sulfates and coxsackievirus-adenovirus receptor: each one mediates coxsackievirus B3 PD infection J. Virol. 77:10071-10077. (Pubitemid 37122088)